New Leaf Venture Partners is an early and growth-stage venture capital firm exclusively focused on healthcare technology. They invest across biopharmaceuticals, information convergence, medical devices, and life science tools, aiming to partner with innovative companies that have the potential for significant patient impact and strong commercial viability.
Portfolio
4
Fund Size
$1.1B
Top Stage
Series B
Last 12 Mo
0
Stage Distribution
Portfolio
4 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Arine | Series B | $29M | Aug 2022 |
| Cleerly Coronary | Series B | $43M | Jun 2021 |
| Arvinas LLC | Series C | $55M | Apr 2018 |
| AiCure | Series A | $12.3M | Jan 2016 |
Top Co-Investors
Nextech Invest1 shared
Deerfield1 shared
Hillhouse Capital1 shared
Canaan Partners1 shared
RA Capital Management1 shared
OrbiMed1 shared
MBX Capital1 shared
Katalyst Ventures1 shared
Vensana Capital1 shared
DigiTx Partners1 shared
Cigna Ventures1 shared
Pritzker Group Venture Capital1 shared
Tribeca Venture Partners1 shared
Last updated: 3 March 2026